Maria Frank-Kamenetsky
36Patents
11h-index
43Co-inventors
75Inventor score
Filing activity: Sep 17, 2002 → Apr 6, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7605251B2 | Compositions and methods for inhibiting expression of the PCSK9 gene | Chemistry; Metallurgy | 149 | Active |
| US7582745B2 | Compositions and methods for inhibiting expression of Nav1.8 gene | Chemistry; Metallurgy | 146 | Active |
| US7115653B2 | Small organic molecule regulators of cell proliferation | Chemistry; Metallurgy | 110 | Expired |
| US9051567B2 | Methods for increasing efficacy of lipid formulated siRNA | Chemistry; Metallurgy | 92 | Active |
| US10450568B2 | Oligonucleotide compositions and methods thereof | Chemistry; Metallurgy | 49 | Active |
| US9322018B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 27 | Active |
| US9771591B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 16 | Active |
| US10557139B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US10550390B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US10337010B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US8222222B2 | Compositions and methods for inhibiting expression of the PCSK9 gene | Chemistry; Metallurgy | 12 | Active |
| US8852937B2 | Small organic molecule regulators of cell proliferation | Chemistry; Metallurgy | 11 | Active |
| US10053689B2 | Methods for increasing efficacy of lipid formulated siRNA | Chemistry; Metallurgy | 7 | Active |
| US7919473B2 | IRNA agents targeting VEGF | Chemistry; Metallurgy | 6 | Expired |
| US8809292B2 | Compositions and methods for inhibiting expression of the PCSK9 gene | Chemistry; Metallurgy | 5 | Active |
| US7947659B2 | iRNA agents targeting VEGF | Chemistry; Metallurgy | 5 | Expired |
| US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US8293719B2 | iRNA agents targeting VEGF | Chemistry; Metallurgy | 5 | Active |
| US11603532B2 | Oligonucleotide compositions and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US11634710B2 | Oligonucleotide compositions and methods thereof | Chemistry; Metallurgy | 4 | Active |
| US10125369B2 | PCSK9 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US11332743B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11306315B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US10934545B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.